To include your compound in the COVID-19 Resource Center, submit it here.

Califf gets precise

How Califf sees FDA's role in the Precision Medicine Initiative

During a fireside chat with FDA Commissioner Robert Califf at the BIO International Convention, BioCentury asked about FDA's role in the Precision Medicine Initiative. For the record, our question and his answer follow.

BioCentury: FDA has a big role in making the Precision Medicine Initiative happen. One of the elements is next-generation sequencing. That's something you've personally worked on a lot. What are your thoughts about the regulatory environment for NGS, why are you devoting a lot of time to it, and why is it important?

Robert Califf: One reason I'm devoting time to it is the president personally told me to do it. One thing I've learned in Washington is if the

Read the full 1125 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE